The government is counting on a vaccine to bring life and the economy back on track but seroprevalance studies suggest that a significant share of the population has experienced Covid-19 and already has the antibodies. Rather than focusing on getting the vaccine out on scale, Ajay Shah argues here that the release of data on seroprevalence, created through scientific surveys in each city, every week, would be a more relevant path to normalcy. Other views look at the government’s demands on public sector units, the honey adulteration scandal and the jumbo antitrust suit against Facebook. Kanika Datta sums up the views
Along with